These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34424282)

  • 1. Functional protection in J20/VLW mice: a model of non-demented with Alzheimer's disease neuropathology.
    Dávila-Bouziguet E; Casòliba-Melich A; Targa-Fabra G; Galera-López L; Ozaita A; Maldonado R; Ávila J; Delgado-García JM; Gruart A; Soriano E; Pascual M
    Brain; 2022 Apr; 145(2):729-743. PubMed ID: 34424282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
    Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
    Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential accumulation of Tau phosphorylated at residues Thr231, Ser262 and Thr205 in hippocampal interneurons and its modulation by Tau mutations (VLW) and amyloid-β peptide.
    Dávila-Bouziguet E; Targa-Fabra G; Ávila J; Soriano E; Pascual M
    Neurobiol Dis; 2019 May; 125():232-244. PubMed ID: 30553886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CB2 receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
    Koppel J; Vingtdeux V; Marambaud P; d'Abramo C; Jimenez H; Stauber M; Friedman R; Davies P
    Mol Med; 2014 Mar; 20(1):29-36. PubMed ID: 24722782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
    Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice.
    Kocherhans S; Madhusudan A; Doehner J; Breu KS; Nitsch RM; Fritschy JM; Knuesel I
    J Neurosci; 2010 Jul; 30(27):9228-40. PubMed ID: 20610758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice.
    Tapia-Rojas C; Inestrosa NC
    J Neurochem; 2018 Feb; 144(4):443-465. PubMed ID: 29240990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-occurrence of Alzheimer's disease ß-amyloid and τ pathologies at synapses.
    Takahashi RH; Capetillo-Zarate E; Lin MT; Milner TA; Gouras GK
    Neurobiol Aging; 2010 Jul; 31(7):1145-52. PubMed ID: 18771816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional differences in Alzheimer's disease pathology confound behavioural rescue after amyloid-β attenuation.
    Morrone CD; Bazzigaluppi P; Beckett TL; Hill ME; Koletar MM; Stefanovic B; McLaurin J
    Brain; 2020 Jan; 143(1):359-373. PubMed ID: 31782760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.
    Serrano-Pozo A; William CM; Ferrer I; Uro-Coste E; Delisle MB; Maurage CA; Hock C; Nitsch RM; Masliah E; Growdon JH; Frosch MP; Hyman BT
    Brain; 2010 May; 133(Pt 5):1312-27. PubMed ID: 20360050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ErbB4 mediates amyloid β-induced neurotoxicity through JNK/tau pathway activation: Implications for Alzheimer's disease.
    Zhang H; Zhang L; Zhou D; Li H; Xu Y
    J Comp Neurol; 2021 Oct; 529(15):3497-3512. PubMed ID: 34212389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
    Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
    Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional Signatures of Tau and Amyloid Neuropathology.
    Castanho I; Murray TK; Hannon E; Jeffries A; Walker E; Laing E; Baulf H; Harvey J; Bradshaw L; Randall A; Moore K; O'Neill P; Lunnon K; Collier DA; Ahmed Z; O'Neill MJ; Mill J
    Cell Rep; 2020 Feb; 30(6):2040-2054.e5. PubMed ID: 32049030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CB₂ receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
    Koppel J; Vingtdeux V; Marambaud P; d'Abramo C; Jimenez H; Stauber M; Friedman R; Davies P
    Mol Med; 2013 Nov; 19(1):357-64. PubMed ID: 24408112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
    Liu HL; Zhao G; Zhang H; Shi LD
    Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkin deletion causes cerebral and systemic amyloidosis in human mutated tau over-expressing mice.
    Rodríguez-Navarro JA; Gómez A; Rodal I; Perucho J; Martinez A; Furió V; Ampuero I; Casarejos MJ; Solano RM; de Yébenes JG; Mena MA
    Hum Mol Genet; 2008 Oct; 17(20):3128-43. PubMed ID: 18640988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of a selective β2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease.
    Branca C; Wisely EV; Hartman LK; Caccamo A; Oddo S
    Neurobiol Aging; 2014 Dec; 35(12):2726-2735. PubMed ID: 25034342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Melanocyte stimulating hormone prevents GABAergic neuronal loss and improves cognitive function in Alzheimer's disease.
    Ma K; McLaurin J
    J Neurosci; 2014 May; 34(20):6736-45. PubMed ID: 24828629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice.
    Liraz O; Boehm-Cagan A; Michaelson DM
    Mol Neurodegener; 2013 May; 8():16. PubMed ID: 23684315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
    Ruan Z; Pathak D; Venkatesan Kalavai S; Yoshii-Kitahara A; Muraoka S; Bhatt N; Takamatsu-Yukawa K; Hu J; Wang Y; Hersh S; Ericsson M; Gorantla S; Gendelman HE; Kayed R; Ikezu S; Luebke JI; Ikezu T
    Brain; 2021 Feb; 144(1):288-309. PubMed ID: 33246331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.